|27th November 2020||Matthew K Szot||2,339||Grant/award etc.||$0.00|
|1st October 2020||Matthew K Szot||1,039||Exercise of derivative||$0.00|
|1st October 2020||Matthew K Szot||15,919||Grant/award etc.||$0.00|
|1st October 2020||Matthew K Szot||1,397||Payment by withholding||$2.41||$3,366.77|
|1st July 2020||Matthew K Szot||1,701||Payment by withholding||$2.36||$4,014.36|
|1st July 2020||Matthew K Szot||1,010||Exercise of derivative||$0.00|
|1st July 2020||Matthew K Szot||1,039||Exercise of derivative||$0.00|
|18th June 2020||Jamie Bechtel Morrison||1,198||Exercise of derivative||$0.00|
|18th June 2020||Julia Ann Williams||423||Exercise of derivative||$0.00|
|18th June 2020||Matthew K Szot||846||Exercise of derivative||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
SenesTech's first fertility control product candidate is ContraPest. The company was founded by Loretta P. Mayer and Cheryl A. Dyer in July 2004 and is headquartered in Flagstaff, AZ.